Home Investors Media & Resources

Media & investor resources

Key information and updates for BlinkLab investors.

Investor presentations

Corporate Presentation (September 2026)

Investor Presentation – Ignite Investment Summit (April 2026)

Media & interviews

JMM East Coast Investor Lunch: BlinkLab Chairman Mr Brian Leedman presenting (July 2026)

JMM East Coast Investor Lunch

August 17, 2026

Investor Webinar: JMM Interview with BlinkLab CEO Dr Henk-Jan Boele (5 August 2026)

Investor Webinar – JMM Interview with BlinkLab Limited (ASX:BB1)

JMM Expert Insights: Interview with BlinkLab Chairman Mr Brian Leedman (July 2026)

JMM Expert Insights

Stocks in the Vines: Investor Access Day 2026 (BlinkLab Chairman Mr Brian Leedman)

Stocks in the Vines (Mines in the Vines Events)

BlinkLab advances smartphone-based diagnostics for autism and ADHD: Sharecafe's Sip & Learn with BlinkLab Chairman Mr Brian Leedman

Finance News Network's Sharecafe

How BlinkLab Limited is Building AI Diagnostics for Autism and ADHD: Interview with BlinkLab Chairman Mr Brian Leedman

National Implementation Program & Pivotal U.S. Trial Advancement: Leadership Talks with BlinkLab CEO Dr Henk-Jan Boele

East Coast Research - Leadership Talks

BlinkLab Teams Up with Morocco for Autism Screening Program: AusBiz Interview with BlinkLab Chairman Mr Brian Leedman

AusBiz - The Close

How AI-powered Smartphone Neurological Testing Advances Early Autism and ADHD Diagnosis: Leadership Talks with BlinkLab Chairman Mr Brian Leedman

East Coast Research - Leadership Talks

February 9, 2026

The Stock Network's ASX Gems Investment Conference: BlinkLab CEO Dr Henk-Jan Boele

The Stock Network

December 22, 2025

BlinkLab Delivers 84% Clinical-grade Accuracy in Pilot Study: Leadership Talks with BlinkLab CEO Dr Henk-Jan Boele

East Coast Research - Leadership Talks

November 17, 2025

Diagnosing Autism and ADHD from a Smartphone: JMM Interview with BlinkLab CEO Dr Henk-Jan Boele

Finance News Network

BlinkLab in the media

View all media mentions

BlinkLab Reports Positive ADHD Study Results to Expand AI Diagnostic Platform

Kalkine Media – Sonal Goyal

BlinkLab Achieves 82% Sensitivity and 83% Specificity in European ADHD Digital Biomarker Study

New smartphone app could revolutionise autism diagnosis in Australia

Kalkine Media – Mukul

BlinkLab expands clinical study portfolio beyond autism diagnostics

Herald Sun (Stockhead)

Healthcare innovation pours into the Yarra Valley

Analyst coverage

Independent investment analysis and research reports on BlinkLab, provided by third-party analysts.

Bioshares, Australia's Independent Biotech Investment Resource

Bioshares, Australia's Independent Biotech Investment Resource

ADHD Breakthrough Expands the Opportunity | Autism Dx1 Advances Towards FDA Approval

Blinklab Positive ADHD results — a major milestone

Morgans Financial - Initiation: "Blink and you will miss important milestones"

Bioshares, Australia's Independent Biotech Investment Resource

Bioshares, Australia's Independent Biotech Investment Resource

Lodge Partners Research Update - Pilot Study Confirms Path to Commerciality

Outstanding USA Pilot Results Set the Path for 2026 FDA Clearance

Bioshares, Australia's Independent Biotech Investment Resource

Revolutionising Autism and ADHD Diagnosis with AI-Powered smartphone technology

Lodge Partners - Initiation Research Report - BlinkLab Ltd (ASX:BB1) ASD & ADHD Diagnostic App

Bioshares, Australia’s Independent Biotech Investment Resource

ASX announcements

Latest ASX announcements and company updates, including research milestones, commercial progress, and corporate actions.

View all ASX announcements

Loading...
Loading...
Download